Epoprostenol and nitric oxide therapy for severe pulmonary hypertension in liver transplantation.
Baylor University Medical Center, Dallas, Texas, USA.
E P
EP
Molmenti
M
M
Ramsay
K
K
Ramsay
K
K
Lynch
H A
HA
Tillmann Hein
H
H
Molmenti
M
M
Levy
R
R
Goldstein
K
K
Ausloos
C
C
East
C
C
Fasola
G
G
Jung
J
J
Escobar
G
G
Klintmalm
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D011464:Epoprostenol / Q000627:therapeutic use*; D005240:Feasibility Studies; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology; D017093:Liver Failure / Q000150:complications / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects*; D008875:Middle Aged; D009569:Nitric Oxide / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D014665:Vasodilator Agents; D009569:Nitric Oxide; D011464:Epoprostenol